Clinical Trial Update: A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study to determine the effect of the investigational drug SEP-363856 on the pharmacokinetics of metformin in people with schizophrenia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEP-363856
• metformin (metformin)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED